|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/864 | (2006.01) |
| C12N2750/14143 | (2013.01) | ||
| A61K 38/47 | (2006.01) | ||
| A61K 38/47 | (2013.01) | ||
| A61K 48/00 | (2006.01) | ||
| A61K 48/0058 | (2013.01) | ||
| A61K 35/76 | (2015.01) | ||
| C12N2750/14171 | (2013.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61P 25/16 | (2018.01) | ||
| C12N 9/24 | (2006.01) | ||
| A61K 35/76 | (2013.01) | ||
| C12Y 302/01045 | (2013.01) | ||
| A01K2267/0356 | (2013.01) | ||
| A01K2227/105 | (2013.01) | ||
| C12N 9/2405 | (2013.01) |
| (11) | Patento numeris | 3292206 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16724546.3 |
| Europos patento paraiškos padavimo data | 2016-05-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-12-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/031223 |
| Data | 2016-05-06 |
| (87) | Numeris | WO 2016/179497 |
| Data | 2016-11-10 |
| (30) | Numeris | Data | Šalis |
| 201562158244 P | 2015-05-07 | US |
| (72) |
PARK, Yung Hee , US
ISACSON, Ole , US
|
| (73) |
Shire Human Genetic Therapies, Inc. ,
300 Shire Way, Lexington, MA 02421,
US
The McLean Hospital Corporation , 115 Mill Street, Belmont, MA 02478, US |
| (54) | GLUCOCEREBROSIDASE GENE THERAPY FOR PARKINSON'S DISEASE |
| GLUCOCEREBROSIDASE GENE THERAPY FOR PARKINSON'S DISEASE |